Home LiteratureArticle Details
PMID: 3399292 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.

Pediatrics ·Vol. 82 ·No. 2 ·1988-08-00 ·Pages 199-203

Groothuis JR, Gutierrez KM, Lauer BA

Abstract

Little is known about the risk of severe illness from respiratory syncytial virus infection in children with bronchopulmonary dysplasia. A prospective study was done of the natural history of respiratory syncytial virus infection in 30 children less than 2 years of age with bronchopulmonary dysplasia who were in a home oxygen program. Surveillance to identify children with acute respiratory symptoms was done by weekly telephone interview. Symptomatic children were examined, oxygen saturation was determined by oximetry, and nasopharyngeal lavage fluid was collected for virus cultures and rapid respiratory syncytial virus antigen tests. During the 4-month study period (December to April), 27 children had one or more acute respiratory illnesses, and respiratory syncytial virus developed in 16/27 (59%). Passive smoking and greater than or equal to four members in the home increased the risk of symptomatic respiratory syncytial virus (P less than .01 and P less than .03, respectively). Of 16 children, 11 (69%) required hospitalization. Of the 11 hospitalized children with respiratory syncytial virus, nine were either still receiving oxygen at home or required oxygen therapy within the previous 3 months v none of five nonhospitalized children (P less than .005). Five of the hospitalized children were greater than 12 months of age and five had respiratory syncytial virus infection previously that had been confirmed by culture results. Hospitalizations were prolonged and complicated. Seven of 11 children were hospitalized for greater than 1 week; four were admitted to the intensive care unit; four were treated with ribavirin aerosol, and two needed mechanical ventilation. There were no deaths.(ABSTRACT TRUNCATED AT 250 WORDS)

MeSH Terms
Bronchopulmonary Dysplasia/complications,therapy Hospitalization Humans Infant Infant, Newborn Oxygen/therapeutic use Respiratory Syncytial Viruses Respirovirus Infections/etiology Risk Factors Tobacco Smoke Pollution/adverse effects
Chemicals
Tobacco Smoke Pollution Oxygen
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Groothuis J R
Department of Pediatrics, University of Colorado School of Medicine, Denver 80262.
Gutierrez K M
Lauer B A
Article Info
Journal
Pediatrics
Abbr.
Pediatrics
ISSN
0031-4005
Published
1988-08-00
Pages
199-203
Language
English
Region
United States
NLM ID
0376422
Subset
IM
Grants
DRS NIH HHS · BRSG-05357 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com